|
Class
|
Product Group
|
Product
|
Species
|
Description
|
Raybiotech Catalog
|
Size
|
List Price
|
|
Peptide
|
Synthetic peptide
|
Antagonist G
|
|
MF: C49H62O6N12S, MW: 951.2(H-Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2)
|
CG55256
|
0.5 mg
|
130.00
|
|
Peptide
|
Synthetic peptide
|
Antagonist G
|
|
MF: C49H62O6N12S, MW: 951.2(H-Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2)
|
CG55256
|
1 mg
|
180.00
|
|
Peptide
|
Synthetic peptide
|
Antagonist G
|
|
MF: C49H62O6N12S, MW: 951.2(H-Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2)
|
CG55256
|
2.5 mg
|
270.00
|
|
Peptide
|
Synthetic peptide
|
Antiestrogen
|
|
MF: C64H103N13O22S1P1, MW: 1469.65(H-Cys-Asn-Val-Val-Pro-Leu-Tyr(PO3H2)-Asp-Leu-Leu-Leu-Glu-OH)
|
CG55391
|
2.5 mg
|
190.00
|
|
Peptide
|
Synthetic peptide
|
Antiestrogen
|
|
MF: C64H103N13O22S1P1, MW: 1469.65(H-Cys-Asn-Val-Val-Pro-Leu-Tyr(PO3H2)-Asp-Leu-Leu-Leu-Glu-OH)
|
CG55391
|
0.5 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
Antiestrogen
|
|
MF: C64H103N13O22S1P1, MW: 1469.65(H-Cys-Asn-Val-Val-Pro-Leu-Tyr(PO3H2)-Asp-Leu-Leu-Leu-Glu-OH)
|
CG55391
|
1 mg
|
130.00
|
|
Peptide
|
Synthetic peptide
|
Apamin
|
|
MF: C79H131N31O24S4, MW: 2027.37(H-Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-
Arg-Cys-Gln-Gln-His-NH2(Cys1-Cys11, Cys3-Cys15)) |
CG55551
|
0.5 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
Apamin
|
|
MF: C79H131N31O24S4, MW: 2027.37(H-Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-
Arg-Cys-Gln-Gln-His-NH2(Cys1-Cys11, Cys3-Cys15)) |
CG55551
|
1 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
Apamin
|
|
MF: C79H131N31O24S4, MW: 2027.37(H-Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-
Arg-Cys-Gln-Gln-His-NH2(Cys1-Cys11, Cys3-Cys15)) |
CG55551
|
2.5 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
Apelin-13
|
human, bovine
|
MF: C69H111N23O16S, MW: 1550.86(H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH)
|
CG55401
|
0.5 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
Apelin-13
|
human, bovine
|
MF: C69H111N23O16S, MW: 1550.86(H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH)
|
CG55401
|
2.5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
Apelin-13
|
human, bovine
|
MF: C69H111N23O16S, MW: 1550.86(H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH)
|
CG55401
|
1 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
Apelin-C-terminus
|
human, mouse, rat
|
MF:C49H83N13O17S1, MW: 1158.33,(Cys-Leu-Ser-Glu-Ala-Gly-Leu-Lys-Gly-Pro-Pro-Ser),
Regular peptide
|
RB60001
|
100΅g
|
50
|
|
Peptide
|
Synthetic peptide
|
Apelin-C-terminus
|
human, mouse, rat
|
MF:C49H83N13O17S1, MW: 1158.33,(biotin-Cys-Leu-Ser-Glu-Ala-Gly-Leu-Lys-Gly-Pro-Pro-Ser),
Biotinrylated at N-terminus |
RB60001B
|
100΅g
|
80
|
|
Peptide
|
Synthetic peptide
|
Apelin-N-terminus
|
human, mouse, rat
|
MF:C60H108N22O22S1, MW:1521.71, (Cys-Ser-Leu-Asp-Asp-Ser-Arg-Ser-Leu-Thr-Arg-Ile-Arg),
Regular peptide |
RB60000
|
100΅g
|
50
|
|
Peptide
|
Synthetic peptide
|
Apelin-N-terminus
|
human, mouse, rat
|
MF:C60H108N22O22S1, MW:1521.71, (biotin-Cys-Ser-Leu-Asp-Asp-Ser-Arg-Ser-Leu-Thr-Arg-Ile-Arg),
Biotinrylated at N-terminus |
RB60000B
|
100΅g
|
80
|
|
Peptide
|
Synthetic peptide
|
Atrial Natriuretic Peptide (1-28)
|
rat
|
MF: C128H205N45O39S2, MW:
3062.47(H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
(Cys7-Cys23)) |
CG55278
|
0.5 mg
|
150.00
|
|
Peptide
|
Synthetic peptide
|
Atrial Natriuretic Peptide (1-28)
|
rat
|
MF: C128H205N45O39S2, MW:
3062.47(H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
(Cys7-Cys23)) |
CG55278
|
1 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
Atrial Natriuretic Peptide (1-28)
|
rat
|
MF: C128H205N45O39S2, MW:
3062.47(H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
(Cys7-Cys23)) |
CG55278
|
2.5 mg
|
340.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin I
|
|
MF: C83H135N29O30S2, MW:
2083.31(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-OH(Cys7-Cys23))
|
CG55273
|
0.5 mg
|
130.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin I
|
|
MF: C83H135N29O30S2, MW:
2083.31(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-OH(Cys7-Cys23))
|
CG55273
|
1 mg
|
180.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin I
|
|
MF: C83H135N29O30S2, MW:
2083.31(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-OH(Cys7-Cys23))
|
CG55273
|
2.5 mg
|
270.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin II
|
(rat, rabbit, mouse)
|
MF: C98H156N34O32S2, MW:
2386.67(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH(Cys7-Cys23))
|
CG55274
|
2.5 mg
|
360.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin II
|
(rat, rabbit, mouse)
|
MF: C98H156N34O32S2, MW:
2386.67(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH(Cys7-Cys23))
|
CG55274
|
0.5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin II
|
(rat, rabbit, mouse)
|
MF: C98H156N34O32S2, MW:
2386.67(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH(Cys7-Cys23))
|
CG55274
|
1 mg
|
260.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin III
|
|
MF: C107H165N35O34S2, MW:
2549.85(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OHv(Cys7-Cys23))
|
CG55275
|
0.5 mg
|
150.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin III
|
|
MF: C107H165N35O34S2, MW:
2549.85(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OHv(Cys7-Cys23))
|
CG55275
|
1 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
Atriopeptin III
|
|
MF: C107H165N35O34S2, MW:
2549.85(H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OHv(Cys7-Cys23))
|
CG55275
|
2.5 mg
|
340.00
|
|
Peptide
|
Synthetic peptide
|
Auriculin A
|
|
MF: C104H168N38O33S2, MW:
2542.86(H-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH(Cys7-Cys23))
|
CG55276
|
1 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
Auriculin A
|
|
MF: C104H168N38O33S2, MW:
2542.86(H-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH(Cys7-Cys23))
|
CG55276
|
2.5 mg
|
340.00
|
|
Peptide
|
Synthetic peptide
|
Auriculin A
|
|
MF: C104H168N38O33S2, MW:
2542.86(H-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH(Cys7-Cys23))
|
CG55276
|
0.5 mg
|
150.00
|
|
Peptide
|
Synthetic peptide
|
Autocamtide 2
|
|
MF: C65H118N22O20, MW: 1527.8(H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu-OH)
|
CG55398
|
1 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
Autocamtide 2
|
|
MF: C65H118N22O20, MW: 1527.8(H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu-OH)
|
CG55398
|
2 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
Autocamtide 2
|
|
MF: C65H118N22O20, MW: 1527.8(H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu-OH)
|
CG55398
|
5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
Bactenecin
|
bovine
|
MF: C63H118N24O13S2, MW: 1483.9(H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH(Cys3-Cys11))
|
CG52224
|
5 mg
|
190.00
|
|
Peptide
|
Synthetic peptide
|
Bactenecin
|
bovine
|
MF: C63H118N24O13S2, MW: 1483.9(H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH(Cys3-Cys11))
|
CG52224
|
2 mg
|
130.00
|
|
Peptide
|
Synthetic peptide
|
Bactenecin
|
bovine
|
MF: C63H118N24O13S2, MW: 1483.9(H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH(Cys3-Cys11))
|
CG52224
|
1 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
BAM-12P
|
|
MF: C62H97N21O16S1, MW: 1424.66(H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-OH)
|
CG55388
|
1 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
BAM-12P
|
|
MF: C62H97N21O16S1, MW: 1424.66(H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-OH)
|
CG55388
|
2 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
BAM-12P
|
|
MF: C62H97N21O16S1, MW: 1424.66(H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-OH)
|
CG55388
|
5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
BAM-22P
|
|
MF: C130H184N38O31S2, MW:
2839.28(H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH)
|
CG55216
|
2 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
BAM-22P
|
|
MF: C130H184N38O31S2, MW:
2839.28(H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH)
|
CG55216
|
1 mg
|
150.00
|
|
Peptide
|
Synthetic peptide
|
BAM-22P
|
|
MF: C130H184N38O31S2, MW:
2839.28(H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH)
|
CG55216
|
5 mg
|
340.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-40)
|
rat
|
MF: C190H291N51O57S1, MW: 4233.81(H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-)
|
CG53770
|
1 mg
|
280.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-40)
|
rat
|
MF: C190H291N51O57S1, MW: 4233.81(H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-)
|
CG53770
|
2.5 mg
|
460.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-40)
|
rat
|
MF: C190H291N51O57S1, MW: 4233.81(H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-)
|
CG53770
|
0.5 mg
|
190.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-40), Ultra Pure, TFA
|
|
MF: C194H295N53O58S1, MW:
4329.9(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH)
|
CG51516
|
0.5 mg
|
190.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-40), Ultra Pure, TFA
|
|
MF: C194H295N53O58S1, MW:
4329.9(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH)
|
CG51516
|
1 mg
|
280.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-40), Ultra Pure, TFA
|
|
MF: C194H295N53O58S1, MW:
4329.9(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH)
|
CG51516
|
2.5 mg
|
460.00
|
|
Peptide
|
Synthetic peptide
|
b-Amyloid (1-42)
|
human
|
MF: C203H311N55O60S1 , MW:
514.14(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH)
|
CG52487
|
1 mg
|
280.00
|